酒精性-话题@MedSci

#酒精性#

552篇内容 | 2683人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1673658, encodeId=5ac016e36583c, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, objectTitle=Clin Gastroenterol H：非酒精性脂肪肝疾病患儿的孕妇和围产期危险因素, objectType=article, longId=210158, objectId=739b21015868, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=739b21015868, replyNumber=0, likeNumber=80, createdTime=2021-05-12, rootId=0, userName=huiwelcome, userId=398f26933958, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=739b21015868, moduleTitle=Clin Gastroenterol H：非酒精性脂肪肝疾病患儿的孕妇和围产期危险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=739b21015868)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1673649, encodeId=835c16e36495a, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, objectTitle=Clin Trans Gastroenterology：肠道选择性广谱抗生素对酒精性肝炎的细菌移位和全身炎症没有影响, objectType=article, longId=208087, objectId=387b20808e5a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=387b20808e5a, replyNumber=0, likeNumber=92, createdTime=2021-07-12, rootId=0, userName=huiwelcome, userId=398f26933958, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=387b20808e5a, moduleTitle=Clin Trans Gastroenterology：肠道选择性广谱抗生素对酒精性肝炎的细菌移位和全身炎症没有影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=387b20808e5a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1673584, encodeId=af6516e358440, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, objectTitle=非酒精性脂肪性肝炎（NASH）迎来新进展：lanifibranor达到期中研究的主要终点, objectType=article, longId=196006, objectId=cc5f1960069e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc5f1960069e, replyNumber=0, likeNumber=66, createdTime=2021-01-25, rootId=0, userName=huiwelcome, userId=398f26933958, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc5f1960069e, moduleTitle=非酒精性脂肪性肝炎（NASH）迎来新进展：lanifibranor达到期中研究的主要终点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc5f1960069e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1673591, encodeId=301216e359172, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, objectTitle=非酒精性脂肪性肝炎（NASH）新药Namodenoson：所有功效指标均得到显着且持续改善, objectType=article, longId=196884, objectId=c1dc196884ba, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1dc196884ba, replyNumber=0, likeNumber=77, createdTime=2021-01-19, rootId=0, userName=huiwelcome, userId=398f26933958, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1dc196884ba, moduleTitle=非酒精性脂肪性肝炎（NASH）新药Namodenoson：所有功效指标均得到显着且持续改善, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c1dc196884ba)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1673604, encodeId=eb5516e360413, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, objectTitle=Lancet gastroenterol hepatol：鲁比前列酮治疗便秘的非酒精性脂肪性肝病患者的疗效和安全性, objectType=article, longId=199610, objectId=27e819961026, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27e819961026, replyNumber=0, likeNumber=67, createdTime=2021-01-26, rootId=0, userName=huiwelcome, userId=398f26933958, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27e819961026, moduleTitle=Lancet gastroenterol hepatol：鲁比前列酮治疗便秘的非酒精性脂肪性肝病患者的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27e819961026)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1673629, encodeId=82ba16e36290e, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, objectTitle=FDA批准候选药物lanifibranor进入III期临床，以治疗非酒精性脂肪性肝炎（NASH）, objectType=article, longId=203274, objectId=cfcb2032e4c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cfcb2032e4c1, replyNumber=0, likeNumber=53, createdTime=2021-06-10, rootId=0, userName=huiwelcome, userId=398f26933958, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cfcb2032e4c1, moduleTitle=FDA批准候选药物lanifibranor进入III期临床，以治疗非酒精性脂肪性肝炎（NASH）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cfcb2032e4c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1673579, encodeId=546716e35798b, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, objectTitle=Cell Death Dis：SREBP1c类泛素化是非酒精性脂肪肝的潜在治疗靶标, objectType=article, longId=194074, objectId=e9d11940e4df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e9d11940e4df, replyNumber=0, likeNumber=76, createdTime=2020-12-18, rootId=0, userName=huiwelcome, userId=398f26933958, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e9d11940e4df, moduleTitle=Cell Death Dis：SREBP1c类泛素化是非酒精性脂肪肝的潜在治疗靶标, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e9d11940e4df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1673644, encodeId=cfc716e3644f7, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, objectTitle=GUT: 患有非酒精性脂肪肝疾病的瘦子与非瘦患者长期的预后的差别, objectType=article, longId=206867, objectId=10fb20686ecd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10fb20686ecd, replyNumber=0, likeNumber=78, createdTime=2021-07-21, rootId=0, userName=huiwelcome, userId=398f26933958, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10fb20686ecd, moduleTitle=GUT: 患有非酒精性脂肪肝疾病的瘦子与非瘦患者长期的预后的差别, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10fb20686ecd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1673612, encodeId=6e0516e3612b9, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, objectTitle=Liver Int：氧化应激与健康人群的非酒精性脂肪肝疾病发生率和死亡率相关, objectType=article, longId=200829, objectId=ef2f200829fb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef2f200829fb, replyNumber=0, likeNumber=69, createdTime=2020-11-06, rootId=0, userName=huiwelcome, userId=398f26933958, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef2f200829fb, moduleTitle=Liver Int：氧化应激与健康人群的非酒精性脂肪肝疾病发生率和死亡率相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef2f200829fb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1673603, encodeId=958f16e36035a, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, objectTitle=Hepatology：酒精使用障碍和酒精性肝硬化，竟能使用粪便微生物群移植进行治疗？, objectType=article, longId=199472, objectId=728d1994e20b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=728d1994e20b, replyNumber=0, likeNumber=83, createdTime=2020-09-23, rootId=0, userName=huiwelcome, userId=398f26933958, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=728d1994e20b, moduleTitle=Hepatology：酒精使用障碍和酒精性肝硬化，竟能使用粪便微生物群移植进行治疗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=728d1994e20b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1673575, encodeId=f6b716e357535, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, objectTitle=Cell Death Dis：TNFR1或可作为非酒精性脂肪肝的治疗靶点, objectType=article, longId=192469, objectId=33671924695b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33671924695b, replyNumber=0, likeNumber=67, createdTime=2021-03-28, rootId=0, userName=huiwelcome, userId=398f26933958, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33671924695b, moduleTitle=Cell Death Dis：TNFR1或可作为非酒精性脂肪肝的治疗靶点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33671924695b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1673588, encodeId=3ee216e358847, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, objectTitle=Clin Gastroenterology H:非酒精性脂肪肝患者的酒精摄入与肝脂肪变性相关, objectType=article, longId=196736, objectId=6d42196e362e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6d42196e362e, replyNumber=0, likeNumber=21, createdTime=2020-11-12, rootId=0, userName=huiwelcome, userId=398f26933958, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6d42196e362e, moduleTitle=Clin Gastroenterology H:非酒精性脂肪肝患者的酒精摄入与肝脂肪变性相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6d42196e362e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1673590, encodeId=ee0f16e3590ac, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, objectTitle=Am J Clin Nutr：酸奶可改善非酒精性脂肪肝病和代谢综合症女性的胰岛素抵抗和肝脂肪状况, objectType=article, longId=196765, objectId=2a6a196e65e5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2a6a196e65e5, replyNumber=0, likeNumber=70, createdTime=2021-05-30, rootId=0, userName=huiwelcome, userId=398f26933958, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2a6a196e65e5, moduleTitle=Am J Clin Nutr：酸奶可改善非酒精性脂肪肝病和代谢综合症女性的胰岛素抵抗和肝脂肪状况, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2a6a196e65e5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1673619, encodeId=3ee316e361930, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, objectTitle=Metabolism：成年早期体重增加、体形变化与非酒精性脂肪肝疾病风险的关系, objectType=article, longId=202060, objectId=e81720206007, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e81720206007, replyNumber=0, likeNumber=48, createdTime=2021-01-02, rootId=0, userName=docwu2019, userId=a12645, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e81720206007, moduleTitle=Metabolism：成年早期体重增加、体形变化与非酒精性脂肪肝疾病风险的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e81720206007)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1673641, encodeId=0f9816e3641e5, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, objectTitle=J Altern Complement Med：针刺和有氧间歇训练均可有效改善非酒精性脂肪肝患者的肝功能，其中针刺的效果更佳, objectType=article, longId=204313, objectId=85a420431371, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=85a420431371, replyNumber=0, likeNumber=78, createdTime=2021-10-02, rootId=0, userName=huiwelcome, userId=398f26933958, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=85a420431371, moduleTitle=J Altern Complement Med：针刺和有氧间歇训练均可有效改善非酒精性脂肪肝患者的肝功能，其中针刺的效果更佳, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=85a420431371)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1673596, encodeId=506016e3596fb, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, objectTitle=AP&T: 酒精性肝炎患者中的微量元素缺乏症与感染和死亡相关, objectType=article, longId=197799, objectId=d24b19e79977, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d24b19e79977, replyNumber=0, likeNumber=71, createdTime=2020-08-30, rootId=0, userName=huiwelcome, userId=398f26933958, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d24b19e79977, moduleTitle=AP&T: 酒精性肝炎患者中的微量元素缺乏症与感染和死亡相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d24b19e79977)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1673624, encodeId=525316e3624f6, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, objectTitle=Gastroenterology：减肥手术对肥胖的非酒精性脂肪性肝炎的治疗效果, objectType=article, longId=202786, objectId=6396202e8684, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6396202e8684, replyNumber=0, likeNumber=62, createdTime=2020-12-13, rootId=0, userName=huiwelcome, userId=398f26933958, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6396202e8684, moduleTitle=Gastroenterology：减肥手术对肥胖的非酒精性脂肪性肝炎的治疗效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6396202e8684)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1673601, encodeId=306716e3601c1, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, objectTitle=RNAi巨头Alnylam公司再发力：出击非酒精性脂肪性肝炎（NASH）, objectType=article, longId=198731, objectId=37c9198e311c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=37c9198e311c, replyNumber=0, likeNumber=67, createdTime=2021-04-18, rootId=0, userName=huiwelcome, userId=398f26933958, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=37c9198e311c, moduleTitle=RNAi巨头Alnylam公司再发力：出击非酒精性脂肪性肝炎（NASH）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=37c9198e311c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1673642, encodeId=7dd516e3642cc, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, objectTitle=Stroke：非酒精性脂肪肝严重程度与缺血性卒中风险的关系, objectType=article, longId=204324, objectId=246f20432414, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=246f20432414, replyNumber=0, likeNumber=63, createdTime=2021-04-02, rootId=0, userName=huiwelcome, userId=398f26933958, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=246f20432414, moduleTitle=Stroke：非酒精性脂肪肝严重程度与缺血性卒中风险的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=246f20432414)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1673593, encodeId=2a7c16e359301, content=<a href='/topic/show?id=757b954e922' target=_blank style='color:#2F92EE;'>#酒精性#</a>, objectTitle=J INTERN MED：非酒精性脂肪肝与心肌机械能效率降低有关, objectType=article, longId=197348, objectId=351219e348b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=351219e348b5, replyNumber=0, likeNumber=118, createdTime=2021-04-15, rootId=0, userName=huiwelcome, userId=398f26933958, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=351219e348b5, moduleTitle=J INTERN MED：非酒精性脂肪肝与心肌机械能效率降低有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=351219e348b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

酒精性

2020-05-29

huiwelcome (审核中...)

前往app查看评论内容

#酒精性#

Clin Gastroenterol H：非酒精性脂肪肝疾病患儿的孕妇和围产期危险因素

2021-05-12

huiwelcome (审核中...)

前往app查看评论内容

#酒精性#

Clin Trans Gastroenterology：肠道选择性广谱抗生素对酒精性肝炎的细菌移位和全身炎症没有影响

2021-07-12

huiwelcome (审核中...)

前往app查看评论内容

#酒精性#

非酒精性脂肪性肝炎（NASH）迎来新进展：lanifibranor达到期中研究的主要终点

2021-01-25

huiwelcome (审核中...)

前往app查看评论内容

#酒精性#

非酒精性脂肪性肝炎（NASH）新药Namodenoson：所有功效指标均得到显着且持续改善

2021-01-19

huiwelcome (审核中...)

前往app查看评论内容

#酒精性#

Lancet gastroenterol hepatol：鲁比前列酮治疗便秘的非酒精性脂肪性肝病患者的疗效和安全性

2021-01-26

huiwelcome (审核中...)

前往app查看评论内容

#酒精性#

FDA批准候选药物lanifibranor进入III期临床，以治疗非酒精性脂肪性肝炎（NASH）

2021-06-10

huiwelcome (审核中...)

前往app查看评论内容

#酒精性#

Cell Death Dis：SREBP1c类泛素化是非酒精性脂肪肝的潜在治疗靶标

2020-12-18

huiwelcome (审核中...)

前往app查看评论内容

#酒精性#

GUT: 患有非酒精性脂肪肝疾病的瘦子与非瘦患者长期的预后的差别

2021-07-21

huiwelcome (审核中...)

前往app查看评论内容

#酒精性#

Liver Int：氧化应激与健康人群的非酒精性脂肪肝疾病发生率和死亡率相关

2020-11-06

huiwelcome (审核中...)

前往app查看评论内容

#酒精性#

Hepatology：酒精使用障碍和酒精性肝硬化，竟能使用粪便微生物群移植进行治疗？

2020-09-23

huiwelcome (审核中...)

前往app查看评论内容

#酒精性#

Cell Death Dis：TNFR1或可作为非酒精性脂肪肝的治疗靶点

2021-03-28

huiwelcome (审核中...)

前往app查看评论内容

#酒精性#

Clin Gastroenterology H:非酒精性脂肪肝患者的酒精摄入与肝脂肪变性相关

2020-11-12

huiwelcome (审核中...)

前往app查看评论内容

#酒精性#

Am J Clin Nutr：酸奶可改善非酒精性脂肪肝病和代谢综合症女性的胰岛素抵抗和肝脂肪状况

2021-05-30

docwu2019 (审核中...)

前往app查看评论内容

#酒精性#

Metabolism：成年早期体重增加、体形变化与非酒精性脂肪肝疾病风险的关系

2021-01-02

huiwelcome (审核中...)

前往app查看评论内容

#酒精性#

J Altern Complement Med：针刺和有氧间歇训练均可有效改善非酒精性脂肪肝患者的肝功能，其中针刺的效果更佳

2021-10-02

huiwelcome (审核中...)

前往app查看评论内容

#酒精性#

AP&T: 酒精性肝炎患者中的微量元素缺乏症与感染和死亡相关

2020-08-30

huiwelcome (审核中...)

前往app查看评论内容

#酒精性#

Gastroenterology：减肥手术对肥胖的非酒精性脂肪性肝炎的治疗效果

2020-12-13

huiwelcome (审核中...)

前往app查看评论内容

#酒精性#

RNAi巨头Alnylam公司再发力：出击非酒精性脂肪性肝炎（NASH）

2021-04-18

huiwelcome (审核中...)

前往app查看评论内容

#酒精性#

Stroke：非酒精性脂肪肝严重程度与缺血性卒中风险的关系

2021-04-02

huiwelcome (审核中...)

前往app查看评论内容

#酒精性#

J INTERN MED：非酒精性脂肪肝与心肌机械能效率降低有关

2021-04-15

科室
- - 订阅+
  - 更多科室
工具
服务